Samsung Electronics Co., Ltd. announced today that the Sleep Apnea feature on the Galaxy Watch series, available via the Samsung Health Monitor app, is now officially expanded to 34 European markets, as well as Australia and Singapore. This brings the total number of supported markets globally to 70.
The expansion follows the acquisition of the CE marking (Conformité Européenne) for the European Economic Area (EEA), confirming compliance with EU health, safety, and environmental standards. Additionally, the feature has been approved by Australia's Therapeutic Goods Administration (TGA) and Singapore's Health Sciences Authority (HSA).
This milestone builds on prior approvals from the U.S. FDA, Korea's MFDS, Brazil's ANVISA, and Health Canada. Samsung continues to enhance sleep health tools for users worldwide.